葛兰素史克创办发展史

清风无嗔

葛兰素史克创办发展史

葛兰素史克创办发展史

Our history

GlaxoSmithKline started operations on 1 January 2001 following the merger of GlaxoWellcome plc and SmithKline Beecham plc, but our combined histories go back much further than that. Find out about the many products and mergers that led to the GSK we know today.

Jump to: 1800s1900-19491950-19992000s

1700s

1715

Plough Court Pharmacy established

Plough Court pharmacy is established, the forerunner of Allen and Hanburys, in London by Silvanus Bevan. The A&H name continues today.

Return to top

1800s



1830

John K Smith opens his first drugstore



1842

Beecham’s Pills brand launches



1865

Mahlon Kline joins Smith & Shoemaker



1873

Joseph Nathan and Co is founded



1880

Burroughs Wellcome and Company is established



1886

Burroughs Wellcome registers ‘Tabloid’ trademark

1891

Smith, Kline and Company acquires French, Richards and Company

The original company that John K Smith founded went through numerous mergers and acquisitions. Probably the most important was the company's absorption in of French, Richards and Company, another respected drug wholesaler.

Return to top

1900-1949



1906

‘Glaxo’ trademark is registered

Return to top

1950-1999

1963

Betnovate is launched

Betnovate was the first of Glaxo's range of steroid skin disease treatments. In the mid-1960s, Smith Kline & French also acquired RIT (Recherche et Industrie Therapeutiques), a vaccines business.

1969

Ventolin is launched

Glaxo launches Ventolin as a treatment for asthma, marketed under the Allen & Hanburys name.

1972

Amoxycillin discovered

Scientists at Beecham Research Laboratories discover amoxycillin and launch Amoxil, which will become a widely-used antibiotic



1981

Zantac and various other products launched

1989

SmithKline Beckman and the Beecham Group merge to form SmithKline Beecham plc.



1995

Glaxo and Wellcome merge to form Glaxo Wellcome



1998

SmithKline Beecham and the WHO join forces against LF

Return to top

2000s



2000

Planned merger of Glaxo Wellcome and SmithKline Beecham is announced



2002

The first 100 million albendazole tablets are donated as part of our commitment to fight lymphatic filariasis

2004

Clinical Trial Register launched

The Clinical Trial Register (today the Clinical Study Register) is launched, an internet site containing clinical trial data that anyone can access.



2009

Stiefel acquired - ViiV Healthcare launched

2011

Human Genome Sciences and GSK receive approval for Benlysta, the first new lupus treatment in 50 years



2012

We are an official supplier to the Olympic and Paralympic Games, providing laboratory services for official anti-doping measures

清风无嗔

葛兰素史克创办发展史

我们的历史

葛兰素史克公司开始运作2001年1月1日合并后的GlaxoWellcome PLC和史克必成PLC，但回到我们的合并历史远不止于此。摸透，导致我们今天所知道的葛兰素史克公司的许多产品和兼并。

跳转到：1800s1900-19491950-19992000s

1700年

1715

先灵葆雅法院药房成立

天罡苑药店建立的阿伦和Hanburys的的前身，在伦敦由贝文西拉。 A＆H的名字一直延续到今天。

返回顶部

19世纪



1830

的John K·史密斯打开他的第一家药店



1842

比彻姆丸品牌发布

 

1865

玛伦克莱恩加入史密斯和鞋匠



1873

约瑟夫弥敦道公司成立



1880

宝来惠康公司成立



1886

宝来惠康“小报”商标注册

1891

史密斯，克莱恩和公司收购法国，理查兹和公司的

原公司的John K·史密斯创立了通过大量的兼并和收购。也许最重要的是该公司在法国，理查兹和公司，另一个受人尊敬的药品批发企业吸收。

返回顶部

1900-1949



1906

“葛兰素史克”商标被抢注

返回顶部

1950-1999

1963

Betnovate启动

Betnovate首先是葛兰素史克的类固醇的皮肤疾病治疗范围。史克法国在20世纪60年代中期，还收购了RIT（INDUSTRIE Therapeutiques RECHERCHE等），疫苗业务。

1969年

万托林启动

葛兰素史克公司推出万托林作为治疗哮喘，下的Allen＆Hanburys的名称销售。

1972年

阿莫西林发现

科学家在比彻姆研究实验室发现阿莫西林和Amoxil推出，这将成为一种广泛使用的抗生素



1981

扎特克以及其他多种产品推出

1989

史克贝克曼和比彻姆集团合并，成立史克必成有限公司。

 

1995年

葛兰素威康合并成立葛兰素威康



1998年

史克必成和世卫组织联手对LF

返回顶部

2000

 

2000

葛兰素威康和史克必成公司宣布合并计划

 

2002

作为我们承诺的一部分捐赠的第一个100万阿苯达唑片打淋巴丝虫病

2004

临床试验注册中心推出

临床试验注册中心（临床研究注册）推出后，临床试验数据，任何人都可以访问的互联网网站中包含。



2009

Stiefel的收购 - 欢跃医疗保健推出

2011

人类基因组科学公司和葛兰素史克公司BENLYSTA批准的第一个新的狼疮治疗在50年

 

2012

我们是奥运会和残奥会的官方供应商，提供化验服务，官方的反兴奋剂措施

luckyszy88

学习学习学习

luckyszy88

学习学习学习